Quanta Dialysis Technologies provides an FDA‑cleared hemodialysis platform that supports home, in‑center, SLED, and CRRT treatments on a single compact device. By generating dialysate on demand, it eliminates disposable bags, daily rinses, and chemical disinfection, reducing waste and maintenance while simplifying setup across hospitals, dialysis centers, and home‑care settings.
Funding
$60M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
1OGCFounders
Product
Problem
Patients requiring hemodialysis often face limited access to appropriate treatment settings because existing machines are specialized for a single modality and rely on bulky dialysate bags, daily rinses, and chemical disinfection, creating logistical and operational burdens for hospitals and home care.
Solution
Quanta offers an FDA‑cleared hemodialysis system that delivers all major dialysis modalities—home hemodialysis (HHD), in‑center hemodialysis (IHD), sustained low‑efficiency dialysis (SLED), and continuous renal replacement therapy (CRRT)—from a single platform. The device generates dialysate on demand, eliminating the need for pre‑filled bags, daily rinses, and harsh chemical disinfection, which simplifies setup, reduces waste, and lowers maintenance effort. Its intuitive user interface and flexible flow range (50‑500 mL/min) enable easy training of staff and patients across care settings, from intensive care units to home environments. By consolidating multiple therapies into one compact, bagless system, Quanta expands patient access to high‑quality kidney care wherever it is needed.
Target Audience
Primary customers are hospitals, dialysis centers, and home‑care providers that need a versatile, low‑maintenance dialysis solution for ICU patients, in‑center treatments, and self‑care at home.
Features
- On‑demand dialysate generation removes the requirement for disposable dialysate bags
- Supports four FDA‑cleared modalities (HHD, IHD, SLED, CRRT) on a single device
- Wide therapeutic flow range (50‑500 mL/min) for adaptable treatment prescriptions
- No daily rinses and no harsh chemical disinfection, reducing maintenance workload
- Simple, intuitive touchscreen interface designed for rapid training of clinicians and patients
- Compact, portable form factor suitable for ICU, hospital wards, and home use
- Award‑winning technology recognized with the Royal Academy of Engineering MacRobert Award (2022)